Karimipoor Morteza, Zeinali Sirous, Nafissi Nafiseh, Tuddenham Edward G D, Lak Manijeh, Safaee Reza
Biotechnology Research Centre, Pasteur Institute of Iran, Tehran 13164, Iran.
Thromb Res. 2007;120(1):135-9. doi: 10.1016/j.thromres.2006.07.011. Epub 2006 Oct 2.
Different kinds of mutations, mostly point mutations, in the coagulation factor IX (FIX) gene F9 result in a recessive X-linked bleeding disorder known as haemophilia B. In this study, molecular analysis of 76 unrelated Iranian haemophilia B patients was performed by PCR, single strand conformational polymorphism (SSCP) on important functional regions of the F9 gene followed by sequencing on samples with different migration pattern. Using this approach we found mutation in 52 out of 76 patients. Our data showed that the pathologic mechanisms are heterogeneous as recorded for patients in haemophilia B mutation database and seven of the mutations are previously undescribed.
凝血因子IX(FIX)基因F9中的不同类型突变(大多为点突变)会导致一种隐性X连锁出血性疾病,即乙型血友病。在本研究中,对76名无亲缘关系的伊朗乙型血友病患者进行了分子分析,采用聚合酶链反应(PCR)、对F9基因重要功能区域进行单链构象多态性分析(SSCP),随后对具有不同迁移模式的样本进行测序。通过这种方法,我们在76名患者中的52名发现了突变。我们的数据表明,病理机制具有异质性,这与乙型血友病突变数据库中记录的患者情况一致,且其中7种突变此前未被描述。